{"id":879858,"date":"2025-08-28T04:03:07","date_gmt":"2025-08-28T08:03:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/"},"modified":"2025-08-28T04:03:07","modified_gmt":"2025-08-28T08:03:07","slug":"oculis-to-participate-in-upcoming-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/","title":{"rendered":"Oculis to Participate in Upcoming September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ZUG, Switzerland, Aug.  28, 2025  (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced today that Oculis\u2019 management will participate in upcoming investor conferences in September.<\/p>\n<p>\n        <strong>Wells Fargo Healthcare Conference<\/strong><br \/>\n        <br \/>September 3-5; Boston, U.S.<br \/>Riad Sherif, M.D., Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will attend.<\/p>\n<p>\n        <strong>H.C. Wainwright 27th Annual Global Investment Conference<\/strong><br \/>\n        <br \/>September 8-10; New York, U.S.<br \/>Fireside chat with Riad Sherif, M.D., Chief Executive Officer, scheduled for September 8<sup>th<\/sup> at 2:30 pm ET.<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gThWOtwf4Ew64Pb_lSl_bZpgpOMoakneO22mB-FCSTR3JoKX84o79j1rFoEYkG-N4lwtC0B6uZmjckue7yYNVMHCceTdjA3GbbqlHSnFWTSz-RPphYyJZvxvRDH__YYpXmDNdEXidIyM87DLYwobmg==\" rel=\"nofollow\" target=\"_blank\">Register here<\/a><\/p>\n<p>\n        <strong>Baird Global Healthcare Conference <\/strong><br \/>\n        <br \/>September 9-10; New York, U.S.<br \/>Company update with Riad Sherif, M.D., Chief Executive Officer, scheduled for September 9<sup>th<\/sup> at 3:45 pm ET.<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gThWOtwf4Ew64Pb_lSl_bSFLhKfQlFi-Dn3pfXfKnlCTF8HBqNvVIBpdcRyZsdb3A4kPZM13g4hW4wcO9_waNqMn9Q9CZPmAE3QKW8aN1dsEpi0rO-EkigEcGENfFnRcbeKiQwYqRg034tkF7mkY_Wzi5fJT20jPfwJc-W7peQihpwLl9_tsZk0apby4onsdIyIzGiWPo6KSnhloE6y6VwA-KrJ6k8mSafnjoGCGHK5-unAY-ZpofVVwFK_CDzLdIZACYEUdkiQ6n1Cv7rjNzJCacIfbv1u87Q7au-OWQ_az0fYiMC0HwOMu4a4OsejD3RQR4-CniiBsa2AWDuA5jlTCZqQGHv5l8iJup1MHLmyCom92hFS4k7eGZ9FZc8nKS1Hj2IozhmvzWiU6m8olgTt2n6nPNQRCXXxUoaUbeDxYWa_UqaY1kmD55RCZkmT8sfJz2sH58kLvj2VesY5TxM2VOBYnXGeuM7OIwz6JdRBwjIIZ4Dy4IF5knA_6Pqy5iITOPrs2daDYTHH4kXLJmlCTI2qkxLS3DF2qQhKIeMmGuK8TpSxk1GmoWXndI-14vNkWwZ3yVrsSNnri-8wVKOs7uZ3mwYayvTQnGt8vqucb6EszZgicpCXFU0BCeCAMt7zQ56FzCOZriq_Q_sazyQ==\" rel=\"nofollow\" target=\"_blank\">Register here<\/a><\/p>\n<p>\n        <strong>Pareto Securities 16th Annual Healthcare Conference <\/strong><br \/>\n        <br \/>September 16; Stockholm, Sweden<br \/>Company update with P\u00e1ll Ragnar J\u00f3hannesson, Chief Business Officer, scheduled for September 16<sup>th<\/sup> at 9:15 am CET.<\/p>\n<p>\n        <strong>Leerink Partners Biopharma Summit<\/strong><br \/>\n        <br \/>September 17-19; Healdsburg, U.S.<br \/>Riad Sherif, M.D., Chief Executive Officer, will attend.<\/p>\n<p align=\"justify\">The Company will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at the sponsoring institutions to request meetings.<\/p>\n<p align=\"justify\">Webcast links, when available, will be posted to the Oculis website on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A-ien4jV405E1Acn4QCX72ME_Ovf2wXJZxgHTaNU0kdUAXlO0nE6skXzOO7DajewU41W1YWfupVOmZbnzyZKuUVBgWOM-ZhI33sSWVWt4r4TiRbSVqMczf1zuP0vtvYKFySmp9N90CvE2xYkfajjROgQYSpt5kZ-k7ORpSLjvqZCotc38aL2tcZ5Mspwocooug1P_gaSVPamCzx6754xTRoC4PNmNGI3qSRrp-gU8pdL4Qcoj_XIAMfit8cW7CDOhFKHt75uINnJlvCYrYGxzo9boQ179VdjRcory63Lr3HUGF3KWoB3V2tQ3rn6oY0x6F3292TRZw48Jcvw1pO-pkkxGGnuC4KhL-UMOOdpKD7B3QSZPFTbiJYZ9NtecAGUzXGzkA9B2VKLeeYTr9wls-Bez0nwAf4-m3UjbROjsHvBdiQGpk1c4PlfUpq9Xuevtg5kfIz6NWFXyO1ml2UUvSO0Mc5s5VjJsFiUcO5pLxSDXW-1uHMRNYblAGkaXtjJTb96vcq3TXuwYgFd-GuSNBIr-SR0QdgBcSlzE1ldEirruXgpQ3GEG4uzUHcwkrtf1CSJB-B-aBj0o38-6CxDcA==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentation<\/a>\u00a0page under the Investors &amp; Media section.<\/p>\n<p>\n        <strong>About Oculis<\/strong>\n      <\/p>\n<p align=\"justify\">Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs. Oculis\u2019 highly differentiated late-stage clinical pipeline includes three core product candidates: OCS-01, an eye drop in pivotal registration studies, aiming to become the first non-invasive topical treatment for diabetic macular edema; Privosegtor (OCS-05), a neuroprotective candidate in Phase 2 for acute optic neuritis, with potentially broad clinical applications in various neuro-ophthalmic and neurological diseases; and Licaminlimab (OCS-02), a novel topical anti-TNF\u03b1 in Phase 2, being developed with a genotype-based approach to drive personalized medicine in dry eye disease (DED). Headquartered in Switzerland with operations in the U.S. and Iceland, Oculis is led by an experienced management team with a successful track record and supported by leading international healthcare investors.<\/p>\n<p align=\"justify\">For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mk-KpZbzKVv0Xnq5JZLorpjmOqqNhbCBgpOVlkGbQ9_pJS_ksXfWq8bdlFm6OMoBRIf-Ping4oaY-OWKSZsy_fzQ6IJyFh3v1PCuqGR8GgI=\" rel=\"nofollow\" target=\"_blank\">www.oculis.com<\/a><\/p>\n<p>\n        <strong>Oculis Contacts<\/strong><br \/>\n        <br \/>Ms. Sylvia Cheung, CFO<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ivAJ-njodYc7Gz6yDihAe97nS0tTFw8YnfKd9JXMDloiTyfhnAWkFsSwm41qTaGrfmyBc6gANnvqfoxvMw5j0nPiD4tYU370KLLeoG_ayfmq9mcSUqkAx_nnLOX-MdH9\" rel=\"nofollow\" target=\"_blank\">sylvia.cheung@oculis.com<\/a><\/p>\n<p>\n        <strong>Investor Relations <\/strong><br \/>\n        <br \/>LifeSci Advisors<br \/>Corey Davis, Ph.D.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OebVCQrxTqd2trsYvtgHa6YWGP2L-ZkVdqDJk7tzLXCbvSLxGtp0-PxylqyWXbr-gH-FFjIxIk3a-2x0h5RNmW7W9hZbKUdp5TI-TfGZTcdXepyH2D8HadD-oZdwPx-r\" rel=\"nofollow\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>ICR Healthcare<br \/>Amber Fennell \/ David Daley \/ Sean Leous<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UkBi8FFiLKe3uvcXRszmQkNmEZ28qK1YBxwz-r6w0lfX8z7OOXp0_1zRIwqbKCEti_rYojfTSu4iEQA7me6XSZBSd7Nn0UGgnX-zQaIoQ1hOg10Z0Rpr7MIG9-YIC49e\" rel=\"nofollow\" target=\"_blank\">oculis@icrhealthcare.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MDRiMmExYzQtMTdiOS00Y2YzLTlmMTctZTlkMDdhZDAzOWM1LTEyMDA1NzYtMjAyNS0wOC0yOC1lbg==\/tiny\/Oculis-Holding-AG.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced today that Oculis\u2019 management will participate in upcoming investor conferences in September. Wells Fargo Healthcare Conference September 3-5; Boston, U.S.Riad Sherif, M.D., Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will attend. H.C. Wainwright 27th Annual Global Investment Conference September 8-10; New York, U.S.Fireside chat with Riad Sherif, M.D., Chief Executive Officer, scheduled for September 8th at 2:30 pm ET.Webcast Link: Register here Baird Global Healthcare Conference September 9-10; New York, U.S.Company update with Riad Sherif, M.D., Chief Executive Officer, scheduled for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oculis to Participate in Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-879858","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oculis to Participate in Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oculis to Participate in Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced today that Oculis\u2019 management will participate in upcoming investor conferences in September. Wells Fargo Healthcare Conference September 3-5; Boston, U.S.Riad Sherif, M.D., Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will attend. H.C. Wainwright 27th Annual Global Investment Conference September 8-10; New York, U.S.Fireside chat with Riad Sherif, M.D., Chief Executive Officer, scheduled for September 8th at 2:30 pm ET.Webcast Link: Register here Baird Global Healthcare Conference September 9-10; New York, U.S.Company update with Riad Sherif, M.D., Chief Executive Officer, scheduled for &hellip; Continue reading &quot;Oculis to Participate in Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T08:03:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oculis to Participate in Upcoming September Investor Conferences\",\"datePublished\":\"2025-08-28T08:03:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/\"},\"wordCount\":409,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/\",\"name\":\"Oculis to Participate in Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==\",\"datePublished\":\"2025-08-28T08:03:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oculis to Participate in Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oculis to Participate in Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Oculis to Participate in Upcoming September Investor Conferences - Market Newsdesk","og_description":"ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced today that Oculis\u2019 management will participate in upcoming investor conferences in September. Wells Fargo Healthcare Conference September 3-5; Boston, U.S.Riad Sherif, M.D., Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will attend. H.C. Wainwright 27th Annual Global Investment Conference September 8-10; New York, U.S.Fireside chat with Riad Sherif, M.D., Chief Executive Officer, scheduled for September 8th at 2:30 pm ET.Webcast Link: Register here Baird Global Healthcare Conference September 9-10; New York, U.S.Company update with Riad Sherif, M.D., Chief Executive Officer, scheduled for &hellip; Continue reading \"Oculis to Participate in Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-28T08:03:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oculis to Participate in Upcoming September Investor Conferences","datePublished":"2025-08-28T08:03:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/"},"wordCount":409,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/","name":"Oculis to Participate in Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==","datePublished":"2025-08-28T08:03:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDkzOSM0MDIyMDQyMzYjMjE4OTAyMw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oculis to Participate in Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=879858"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879858\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=879858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=879858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=879858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}